| Authors: |
Burch PM; Pfizer, Inc. Worldwide Research & Discovery, Groton,Connecticut 06340;, Greg Hall D; Eli Lilly & Co., Indianapolis,Indiana 46225;, Walker EG; Critical Path Institute, Predictive Safety Testing Consortium, Tucson, Arizona 85718;, Bracken W; Abbvie Inc., Wyandotte, Michigan 48192;, Giovanelli R; Pfizer, Inc. Worldwide Research & Discovery, Groton,Connecticut 06340;, Goldstein R; Pfizer, Inc. Worldwide Research & Discovery, Groton,Connecticut 06340;, Higgs RE; Eli Lilly & Co., Indianapolis,Indiana 46225;, King NM; Critical Path Institute, Predictive Safety Testing Consortium, Tucson, Arizona 85718;, Lane P; Merck Research Laboratories, West Point, Pennsylvania 19486;, Sauer JM; Critical Path Institute, Predictive Safety Testing Consortium, Tucson, Arizona 85718;, Michna L; Merck Research Laboratories, West Point, Pennsylvania 19486;, Muniappa N; Merck Research Laboratories, West Point, Pennsylvania 19486;, Pritt ML; Eli Lilly & Co., Indianapolis,Indiana 46225;, Vlasakova K; Merck Research Laboratories, West Point, Pennsylvania 19486;, Watson DE; Eli Lilly & Co., Indianapolis,Indiana 46225;, Wescott D; Bristol-Myers Squibb, Princeton, New Jersey 08540., Zabka TS; Genentech, Inc., South San Francisco, California 94080; and., Glaab WE; Merck Research Laboratories, West Point, Pennsylvania 19486; warren_glaab@merck.com. |
